MedCap AB (publ) (STO:MCAP)
561.00
+8.00 (1.45%)
Nov 2, 2026, 5:24 PM CET
MedCap AB Revenue
MedCap AB had revenue of 566.70M SEK in the quarter ending September 30, 2026, with 13.00% growth. This brings the company's total for the last twelve months to 2.32B, up 16.54% year-over-year. In the year 2025, MedCap AB had annual revenue of 2.11B with 16.68% growth. That makes MedCap AB the 16,114th largest company in the world by revenue and 204th in Sweden.
Revenue (ttm)
2.32B
Revenue Growth
+16.54%
P/S Ratio
3.49
Revenue / Employee
3.58M
Employees
663
Market Cap
8.40B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full MedCap AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.11B | 301.30M | 16.68% |
| Dec 31, 2024 | 1.81B | 219.30M | 13.82% |
| Dec 31, 2023 | 1.59B | 476.10M | 42.84% |
| Dec 31, 2022 | 1.11B | 195.00M | 21.28% |
| Dec 31, 2021 | 916.30M | 98.90M | 12.10% |
| Dec 31, 2020 | 817.40M | 60.30M | 7.96% |
| Dec 31, 2019 | 757.10M | 48.10M | 6.78% |
| Dec 31, 2018 | 709.00M | 113.20M | 19.00% |
| Dec 31, 2017 | 595.80M | -255.87M | -30.04% |
| Apr 30, 2017 | 851.67M | 34.75M | 4.25% |
| Apr 30, 2016 | 816.92M | -35.84M | -4.20% |
| Apr 30, 2015 | 852.75M | 26.67M | 3.23% |
| Apr 30, 2014 | 826.09M | 477.05M | 136.67% |
| Apr 30, 2013 | 349.04M | 41.64M | 13.54% |
| Apr 30, 2012 | 307.41M | -8.48M | -2.68% |
| Apr 30, 2011 | 315.89M | 57.10M | 22.06% |
| Apr 30, 2010 | 258.79M | 71.73M | 38.35% |
| Apr 30, 2009 | 187.06M | -1.80M | -0.95% |
| Apr 30, 2008 | 188.86M | 100.18M | 112.98% |
| Apr 30, 2007 | 88.68M | 77.70M | 708.19% |
| Dec 31, 2005 | 10.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.46B |
| Elekta AB | 16.61B |
| Nolato AB | 9.58B |
| Sectra AB | 3.74B |
| Vitrolife AB | 3.44B |
| BICO Group AB | 1.50B |
| Xvivo Perfusion AB | 958.65M |
| CellaVision AB | 763.02M |
MedCap AB News
- 10 days ago - MedCap AB Quarterly report: Q3 2026 - Filings
- 10 days ago - MedCap AB Slides: Q3 2026 - Filings
- 11 days ago - Earnings To Watch: MedCap AB (OSTO:MCAP) Q3 2026 -- GF Value Sees 21% Upside - GuruFocus
- 3 months ago - MedCap AB Quarterly report: Q2 2026 - Filings
- 3 months ago - MedCap AB Slides: Q2 2026 - Filings
- 3 months ago - MedCap AB (OSTO:MCAP) Q2 2026: Everything You Need to Know Ahead of Earnings - GuruFocus
- 6 months ago - MedCap AB Quarterly report: Q1 2026 - Filings
- 6 months ago - MedCap AB Slides: Q1 2026 - Filings